Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95cec123afa373b0980fecd8267c371a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
filingDate |
2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dd63ed021aeb51892606d9989dbd569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d17f58d1de5489b37bdd3ea1aa7efe |
publicationDate |
2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2676663-A2 |
titleOfInvention |
Transdermal delivery system containing galantamine or salts thereof |
abstract |
The present invention provides a transdermal delivery system, which comprises a drug-containing matrix layer comprising: galantamine or its pharmaceutically acceptable salt as an active ingredient; and a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer as an adhesive. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102017115701-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102017115701-B4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758546-B2 |
priorityDate |
2011-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |